Acquisition of segments of BASF's pharmaceutical supply business in Minden (Germany), Evionnaz (Switzerland) and St. Vulbas (France)
Definition of new strategy "Transform". Implementation of a new function-based organization. New investors and capital increase. Sale of the Munich (Germany) subsidiary (Pulmojet project) to Sanofi-Aventis.
Sale of the pharmaceutical production site at
Zofingen to Arena Pharmaceuticals
Launch of a pharmaceutical production facility in Malta. Ramp up of an inhalation technology team in Munich (Germany). Sale of the Sidroga Division and the biotechnology division. Cooperation agreement with Arena Pharmaceuticals.
Cooperation agreement with Celgene
Acquisition of Penick Corporation in New Jersey (USA)
Establishment of a representative office in Shanghai (China)
Integration of Gane's into Siegfried Group
as Siegfried (USA) Inc.
Establishment of two core divisions: Siegfried and Sidroga
Listing on the Swiss Stock Exchange (SWX) in Basel
Founding of Gane's Chemical Works, Inc. (NJ, USA)
Conversion into a joint stock corporation
Founding of a company with 12 employees by pharmacist Samuel Benoni Siegfried to supply pharmacies